NCT02023060 Functional and Quality of Life Improvement Following Transcatheter Heart Valve Implantation
| NCT ID | NCT02023060 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sheba Medical Center |
| Condition | Trans Catheter Aortic Valve |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2013-11 |
| Primary Completion | 2030-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2013-11 with a primary completion date of 2030-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective is to observe trends in patient characteristics and outcomes after aortic or mitral transcatheter heart valve replacement over time.
Eligibility Criteria
Inclusion Criteria: 1. Subject selected for transcatheter heart valve replacement 2. Signed informed consent to participate in the study Exclusion Criteria: 1. Inability to sign written informed consent. 2. Pregnancy or breast feeding (women of childbearing potential will have a serum or urine pregnancy test).
Contact & Investigator
Israel Barbash, MD
📞 +97235305273
Israel Barbash, MD
STUDY CHAIR
Sheba Medical Center, Tel Hashomer
Frequently Asked Questions
Who can join the NCT02023060 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 110 Years, studying Trans Catheter Aortic Valve. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02023060 currently recruiting?
Yes, NCT02023060 is actively recruiting participants. Visit ClinicalTrials.gov or contact Sheba Medical Center to inquire about joining.
Where is the NCT02023060 trial being conducted?
This trial is being conducted at Jerusalem, Israel, Jerusalem, Israel, Petah Tikva, Israel, Ramat Gan, Israel and 1 additional location.
Who is sponsoring the NCT02023060 clinical trial?
NCT02023060 is sponsored by Sheba Medical Center. The principal investigator is Israel Barbash, MD at Sheba Medical Center, Tel Hashomer. The trial plans to enroll 100 participants.